Skip to main content

Table 2 Demographics and clinical characteristics of SFTS patients in the current study

From: Metabolic alterations in urine among the patients with severe fever with thrombocytopenia syndrome

Characteristics

Total (n = 88)

Survival (n = 44)

Fatal (n = 44)

P

Age, years, median (IQR)

73 (68–77)

73 (69–78)

73 (68–77)

0.802

Sex, male, n (%)

43 (48.9)

21 (47.7)

22 (50.0)

0.831

The interval from symptom onset to admission, days, median (IQR)

5 (4–5)

5 (4–6)

5 (4–5)

0.737

The interval from symptom onset to urine sample collection, days, median (IQR)

6 (5–8)

7 (5–8)

6 (5–8)

0.818

Hypertension, n (%)

30 (34.1)

18 (40.9)

12 (27.3)

0.177

General symptoms, n (%)

88 (100.0)

88 (100.0)

88 (100.0)

1.000

Fever

61 (69.3)

31 (70.5)

30 (68.2)

0.817

Chills

20 (22.7)

8 (18.2)

12 (27.3)

0.309

Headache

14 (15.9)

6 (13.6)

8 (18.2)

0.560

Dizziness

24 (27.3)

10 (22.7)

14 (31.8)

0.338

Feeble

84 (95.5)

43 (97.7)

41 (93.2)

0.609

Myalgia

62 (70.5)

33 (75.0)

29 (65.9)

0.350

Lymphadenectasis

59 (67.0)

27 (61.4)

32 (72.7)

0.257

Gastrointestinal symptoms, n (%)

87 (98.9)

43 (97.7)

44 (100.0)

1.000

Anorexia

85 (96.6)

42 (95.5)

43 (97.7)

1.000

Nausea

74 (84.1)

36 (81.8)

38 (86.4)

0.560

Vomit

29 (33.0)

14 (31.8)

15 (34.1)

0.821

Diarrhea

44 (50.0)

15 (34.1)

29 (65.9)

0.003

Bleeding symptoms, n (%)

19 (21.6)

7 (15.9)

12 (27.3)

0.195

Melena

7 (8.0)

2 (4.5)

5 (11.4)

0.431

Hemoptysis

6 (6.8)

4 (9.1)

2 (4.5)

0.672

Haematemesis

3 (3.4)

1 (2.3)

2 (4.5)

1.000

Hematuria

8 (9.1)

1 (2.3)

7 (15.9)

0.064

Petechial

0

0

0

1.000

Neurological symptoms, n (%)

52 (59.1)

17 (38.6)

35 (79.5)

 < 0.001

Dysphoric

26 (29.5)

4 (9.1)

22 (50.0)

 < 0.001

Convulsion

10 (11.4)

5 (11.4)

5 (11.4)

1.000

Blurred Mind

27 (30.7)

4 (9.1)

23 (52.3)

 < 0.001

Coma/Somnolence

41 (46.6)

14 (31.8)

27 (61.4)

0.005

  1. IQR interquartile range, SFTS Severe fever with thrombocytopenia syndrome